Your session is about to expire
← Back to Search
Telehealth Exercise for Multiple Myeloma
N/A
Waitlist Available
Led By Kyuwan Lee
Research Sponsored by City of Hope Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Has undergone autologous stem cell transplant (ASCT) within 30 and 180 days prior to registration
>= 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 8 weeks
Awards & highlights
Study Summary
This trial is testing whether an exercise program delivered through a telehealth platform can help improve physical function and frailty in multiple myeloma survivors.
Who is the study for?
This trial is for adults diagnosed with multiple myeloma who are pre-frail or frail, have had a stem cell transplant within the last 30-180 days, and can perform study tasks. They must not have serious heart issues, exercise contraindications like infections or unstable bone lesions, recent injuries affecting exercise ability, or be doing regular intense exercise.Check my eligibility
What is being tested?
The study tests a telehealth-based exercise program aimed at improving physical function and reducing frailty in multiple myeloma survivors. Participants will follow online videos for exercises focusing on coordination, posture, stretching, balance, and resistance/cardio training.See study design
What are the potential side effects?
Since this intervention involves an exercise program delivered via telehealth without medications involved, side effects may include typical workout-related discomforts such as muscle soreness or strain but should generally be minimal.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I had a stem cell transplant using my own cells between 1 to 6 months ago.
Select...
I am 18 years old or older.
Select...
I have been diagnosed with multiple myeloma.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 8 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 8 weeks
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Physical function
Secondary outcome measures
Frailty index
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Arm A (home-based exercise program)Experimental Treatment3 Interventions
Patients undergo home-based exercise program 3 times per week for 8 weeks. Patients complete questionnaires at baseline (before 1 week) and at weeks 9 and 17.
Group II: Arm B (current activities)Active Control3 Interventions
Patients complete questionnaires at baseline and at week 9 and 17. Patients continue maintaining current activities of daily living and do not participate in any exercise program. Patients may then participate in home-based exercise program 3 times per week for 8 weeks.
Find a Location
Who is running the clinical trial?
City of Hope Medical CenterLead Sponsor
565 Previous Clinical Trials
1,921,427 Total Patients Enrolled
37 Trials studying Multiple Myeloma
3,426 Patients Enrolled for Multiple Myeloma
National Cancer Institute (NCI)NIH
13,654 Previous Clinical Trials
40,933,120 Total Patients Enrolled
578 Trials studying Multiple Myeloma
188,697 Patients Enrolled for Multiple Myeloma
Kyuwan LeePrincipal InvestigatorCity of Hope Comprehensive Cancer Center
2 Previous Clinical Trials
31 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am considered pre-frail or frail based on my weight, energy, walking speed, and muscle strength.I am pregnant or planning to become pregnant.You should not participate if you have a current infection or unstable bone problems that make it unsafe to exercise.I am willing and able to follow all study requirements.I am recovering from an injury that makes rigorous exercise difficult.I have been diagnosed with multiple myeloma.You exercise regularly for more than 60 minutes per week.I had a stem cell transplant using my own cells between 1 to 6 months ago.I am 18 years old or older.I do not have any serious heart conditions like unstable chest pain or uncontrolled irregular heartbeat.
Research Study Groups:
This trial has the following groups:- Group 1: Arm A (home-based exercise program)
- Group 2: Arm B (current activities)
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are there any vacant slots available for prospective participants of this clinical trial?
"According to the information found on clinicialtrials.gov, this research is still actively recruiting patients - it was first posted October 6th 2021 and recently updated March 3rd 2022."
Answered by AI
How many individuals have initiated the research protocol thus far?
"Affirmative. According to the clinicaltrials.gov registry, this trial is currently enrolling participants; initially posted on October 6th 2021 and last modified March 3rd 2022. Sixty volunteers are being accepted across a single medical site."
Answered by AI
Share this study with friends
Copy Link
Messenger